
Cecilia J. Tsang
Examiner (ID: 10028)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1611, 1202, 1675, 1811, 1625, 1654, 2899 |
| Total Applications | 1664 |
| Issued Applications | 1345 |
| Pending Applications | 72 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5585073
[patent_doc_number] => 20090104275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Nanoencapsulation of Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/563012
[patent_app_country] => US
[patent_app_date] => 2006-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 271
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104275.pdf
[firstpage_image] =>[orig_patent_app_number] => 11563012
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/563012 | Nanoencapsulation of Proteins | Nov 22, 2006 | Abandoned |
Array
(
[id] => 5625872
[patent_doc_number] => 20060264377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Chemically modified novel erythropoietin stimulating protein compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/498358
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 6874
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264377.pdf
[firstpage_image] =>[orig_patent_app_number] => 11498358
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/498358 | Chemically modified novel erythropoietin stimulating protein compositions and methods | Aug 1, 2006 | Abandoned |
Array
(
[id] => 5760661
[patent_doc_number] => 20060211606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Peptides'
[patent_app_type] => utility
[patent_app_number] => 11/378624
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18890
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378624 | Peptides | Mar 19, 2006 | Abandoned |
Array
(
[id] => 5095540
[patent_doc_number] => 20070117149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Carbon nanotube binding peptides'
[patent_app_type] => utility
[patent_app_number] => 11/352782
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10925
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117149.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352782 | Carbon nanotube binding peptides | Feb 12, 2006 | Abandoned |
Array
(
[id] => 4727961
[patent_doc_number] => 20080207505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Bna Conjugates and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/813830
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 37317
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207505.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813830
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813830 | Bna Conjugates and Methods of Use | Jan 11, 2006 | Abandoned |
Array
(
[id] => 4898873
[patent_doc_number] => 20080118487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Myostatin Isoform'
[patent_app_type] => utility
[patent_app_number] => 11/576449
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23987
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118487.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576449
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576449 | Myostatin Isoform | Sep 29, 2005 | Abandoned |
Array
(
[id] => 5242830
[patent_doc_number] => 20070021325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability'
[patent_app_type] => utility
[patent_app_number] => 11/188217
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4204
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021325.pdf
[firstpage_image] =>[orig_patent_app_number] => 11188217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/188217 | Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability | Jul 20, 2005 | Abandoned |
Array
(
[id] => 5119406
[patent_doc_number] => 20070141120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Peptide having an ace inhibiting effect'
[patent_app_type] => utility
[patent_app_number] => 10/582759
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4632
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141120.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582759 | Peptide having an ace inhibiting effect | Nov 18, 2004 | Abandoned |
Array
(
[id] => 7360143
[patent_doc_number] => 20040250301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Transgenic animals'
[patent_app_type] => new
[patent_app_number] => 10/639754
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9241
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20040250301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10639754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/639754 | Transgenic animals | Aug 12, 2003 | Abandoned |
Array
(
[id] => 7397217
[patent_doc_number] => 20040038878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Injectable protein formulations'
[patent_app_type] => new
[patent_app_number] => 10/343487
[patent_app_country] => US
[patent_app_date] => 2003-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5632
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343487 | Injectable protein formulations | Jan 30, 2003 | Abandoned |
Array
(
[id] => 6830313
[patent_doc_number] => 20030181371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Compositions and methods of using collajolie'
[patent_app_type] => new
[patent_app_number] => 10/331125
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18839
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181371.pdf
[firstpage_image] =>[orig_patent_app_number] => 10331125
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/331125 | Compositions and methods of using collajolie | Dec 26, 2002 | Abandoned |
Array
(
[id] => 6653071
[patent_doc_number] => 20030105301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Separation of glyco-containing entities'
[patent_app_type] => new
[patent_app_number] => 10/275319
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4756
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275319 | Separation of glyco-containing entities | Nov 4, 2002 | Abandoned |
Array
(
[id] => 6556047
[patent_doc_number] => 20020111496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Inhibitors of glycosyltransferase enzymes'
[patent_app_type] => new
[patent_app_number] => 10/067495
[patent_app_country] => US
[patent_app_date] => 2002-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3443
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067495
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067495 | Inhibitors of glycosyltransferase enzymes | Feb 3, 2002 | Abandoned |
Array
(
[id] => 7127830
[patent_doc_number] => 20050059574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Compositions of stable T3 and methodes of use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/998346
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 6372
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09998346
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998346 | Compositions of stable T3 and methodes of use thereof | Nov 29, 2001 | Abandoned |
Array
(
[id] => 4010536
[patent_doc_number] => 05962477
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Screening methods for cytokine inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/097441
[patent_app_country] => US
[patent_app_date] => 1998-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 46225
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962477.pdf
[firstpage_image] =>[orig_patent_app_number] => 097441
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/097441 | Screening methods for cytokine inhibitors | Jun 14, 1998 | Issued |
Array
(
[id] => 3943440
[patent_doc_number] => 05955057
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Effervescing or foaming bath shape or solid'
[patent_app_type] => 1
[patent_app_number] => 9/096517
[patent_app_country] => US
[patent_app_date] => 1998-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3681
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955057.pdf
[firstpage_image] =>[orig_patent_app_number] => 096517
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/096517 | Effervescing or foaming bath shape or solid | Jun 11, 1998 | Issued |
Array
(
[id] => 3939327
[patent_doc_number] => 05981479
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Cyclosporins'
[patent_app_type] => 1
[patent_app_number] => 9/084709
[patent_app_country] => US
[patent_app_date] => 1998-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7104
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981479.pdf
[firstpage_image] =>[orig_patent_app_number] => 084709
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/084709 | Cyclosporins | May 25, 1998 | Issued |
Array
(
[id] => 3951678
[patent_doc_number] => 05955572
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Structural mimics of RGD-binding sites'
[patent_app_type] => 1
[patent_app_number] => 9/079432
[patent_app_country] => US
[patent_app_date] => 1998-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 10498
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955572.pdf
[firstpage_image] =>[orig_patent_app_number] => 079432
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/079432 | Structural mimics of RGD-binding sites | May 13, 1998 | Issued |
Array
(
[id] => 4048368
[patent_doc_number] => 05968903
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Inhibition of H. pylori proliferation'
[patent_app_type] => 1
[patent_app_number] => 9/074117
[patent_app_country] => US
[patent_app_date] => 1998-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10469
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/968/05968903.pdf
[firstpage_image] =>[orig_patent_app_number] => 074117
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/074117 | Inhibition of H. pylori proliferation | May 6, 1998 | Issued |
Array
(
[id] => 3945560
[patent_doc_number] => 05977067
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them'
[patent_app_type] => 1
[patent_app_number] => 9/069959
[patent_app_country] => US
[patent_app_date] => 1998-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17492
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977067.pdf
[firstpage_image] =>[orig_patent_app_number] => 069959
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/069959 | Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them | Apr 29, 1998 | Issued |